Abstract Number: 675 • ACR/ARP Annual Meeting 2019
Clinical and Serological Lupus Activity Before and After Developing End Stage Renal Disease
Background/Purpose: SLE disease activity tends to diminish after the development of end stage renal disease (ESRD)1, 2. Nonetheless, some patients continue to show signs of…Abstract Number: 2560 • ACR/ARP Annual Meeting 2019
Factors Associated with Hydroxychloroquine Use in Systemic Lupus Erythematosus Patients with End Stage Renal Disease
Background/Purpose: Hydroxychloroquine (HCQ) use in SLE has been associated with a lower risk of end-organ damage, SLE flares, and thrombosis1,2. However the benefits of HCQ…
ACR Meeting Abstracts